The medication does its job. The question is what to do about everything it isn't designed to address: protein adequacy, muscle preservation, micronutrient density, gut function, and the metabolic foundations you'll need beyond the treatment period.

Eating significantly less makes it much harder to meet nutrient requirements through food alone. Iron, B12, vitamin D, zinc, magnesium and protein all become harder to reach without deliberate planning. Filling those gaps matters for energy, mood, immune function, and how you feel through treatment.

Rapid weight loss without adequate protein and resistance training tends to take muscle alongside fat. Less muscle means lower metabolic rate, which makes weight regain easier later. Actively preserving lean body mass during the medication period is one of the most important things you can do.

Slowed gastric emptying is part of how GLP-1 medications work, and it can come with nausea, fullness, and constipation, particularly in the first few weeks. There are practical Naturopathic and dietary approaches that may help take the edge off without compromising the treatment.

Most weight lost on GLP-1 medications is regained after stopping unless the underlying drivers and physiological foundations are addressed during the treatment period. The exit plan matters as much as the medication itself, and it's most effective when started early.

Starting the medication with strong nutritional and metabolic foundations tends to produce better outcomes during treatment and after. Building protein adequacy, gut function and stress regulation before you start gives you more to draw on once the medication takes effect, and more to hold on to when you eventually come off.

GLP-1 receptor agonists are a class of medication that mimic glucagon-like peptide-1, a gut hormone naturally released after eating. They work by stimulating insulin release with food, suppressing glucagon (which raises blood sugar), slowing gastric emptying and signalling satiety to the brain. The result is a significant reduction in appetite and food intake, which leads to weight loss in most people who use them. They're used medically for type 2 diabetes management and, increasingly, for obesity.

The biggest nutritional concern during GLP-1 use is meeting protein requirements despite a much smaller appetite. Inadequate protein during caloric restriction may lead to muscle loss alongside fat loss, which reduces metabolic rate and makes weight maintenance harder after stopping the medication. Micronutrient adequacy is also a concern when overall food volume drops, as it becomes much harder to meet requirements for iron, B12, vitamin D, zinc and magnesium through food alone. A high-quality, nutrient-dense diet with deliberate protein prioritisation, paired with targeted nutritional support, addresses both concerns.

Research consistently shows that a significant portion of weight lost on GLP-1 medications is regained after stopping, often within a year. This is because the medication addresses the appetite signal rather than the underlying drivers that contributed to weight gain in the first place. The degree of regain may be influenced by how the medication period was used: whether muscle mass was preserved through adequate protein and resistance exercise, whether dietary habits shifted in a sustainable way, whether insulin sensitivity and gut health were addressed, and whether the physiological drivers of weight gain were identified and worked on. Stopping without that foundation tends to produce rapid regain.

GLP-1 is a hormone produced naturally by L-cells in the gut lining in response to food. Several nutritional approaches and specific compounds may support its natural release. Dietary fibre, particularly soluble and fermentable types, is one of the most studied. Specific probiotic strains, particularly those that produce short-chain fatty acids, are also areas of research interest. Berberine has documented effects on GLP-1 pathways. The magnitude of these effects is smaller than pharmaceutical doses, and natural approaches aren't equivalent to or a replacement for GLP-1 medications. They sit alongside dietary change as part of a broader metabolic approach.

Nausea is most common in the first few weeks of GLP-1 use and is related to slowed gastric emptying. Eating smaller, more frequent meals, going easy on high-fat and high-fibre foods during the adjustment period, and eating slowly tends to reduce the severity. Ginger, in food or supplement form, has reasonable evidence for nausea relief and is generally well-tolerated alongside GLP-1 medications. Constipation from slowed gut motility is common and may benefit from adequate hydration, soluble fibre and magnesium. For persistent or severe symptoms, a conversation with your prescribing doctor about dose titration is the right next step.

Yes. Supporting your body's natural GLP-1 activity through nutrition and lifestyle is relevant for anyone interested in metabolic health, appetite regulation or blood sugar management, regardless of whether you're using or considering medication. Your gut's natural GLP-1 production plays a role in satiety, insulin response and metabolic rate that's worth supporting independently. Dietary fibre, gut microbiome health, specific botanical medicines and blood sugar regulation approaches all may contribute to healthy endogenous GLP-1 function as part of a broader metabolic approach.

Yes. Every product in our range has been selected by our clinical Naturopaths, so you're welcome to shop the collection independently if you have a clear sense of what you're looking for. If you'd like guidance on which products are most relevant for your situation, our team is available for a free discovery call or a more in-depth consultation.

Yes. Our Naturopaths and Homeopaths are based in Liverpool, Sydney and consult online across Australia. A discovery call is a free, 15-minute introduction and can be booked online. You're also welcome to meet our practitioners to find the right fit for your needs.